View in EDS HTML Full Text PDF Full Text

Reduced-dose anti-thymocyte globulin combined with post-transplant cyclophosphamide versus standard ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation: a focus on chronic GVHD reduction.

Saved in:

Bibliographic Details
Title:	Reduced-dose anti-thymocyte globulin combined with post-transplant cyclophosphamide versus standard ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation: a focus on chronic GVHD reduction.
Authors:	Guo, Wenyi¹ (AUTHOR), Li, Bo¹ (AUTHOR), Tang, Li¹ (AUTHOR), Peng, Liang¹ (AUTHOR), Guo, Shuli¹ (AUTHOR) gwykytx@163.com
Source:	Leukemia & Lymphoma. May2026, Vol. 67 Issue 6, p1385-1395. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	10428194
DOI:	10.1080/10428194.2026.2645932